stockrowNovartis AG
NVS Healthcare Drug Manufacturers General
Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.
- Revenue
- +4.67%
- EPS
- −69.1%
- Free cash flow
- −17.8%
- Total debt
- +53.9%
Quarter to September 2026, against a year earlier
Follow NVS
Alert me
Novartis AG (NVS) Operating margin
Novartis AG's operating margin over the twelve months to 30 September 2026 was 25.2%, down 6.0 percentage points from fiscal 2025 (31.1%). Over the past ten years it has ranged from 16.7% (fiscal 2016) to 31.1% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 31.1% | 3.01 |
| FY2024 | 28.1% | 7.18 |
| FY2023 | 20.9% | 2.66 |
| FY2022 | 18.3% | (3.83) |
| FY2021 | 22.1% | 1.76 |
| FY2020 | 20.4% | 1.68 |
| FY2019 | 18.7% | 0.44 |
| FY2018 | 18.2% | 1.02 |
| FY2017 | 17.2% | 0.49 |
| FY2016 | 16.7% | (1.10) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 12.3% | (19.51) |
| Jun 2026 | 31.8% | 0.46 |
| Mar 2026 | 31.3% | 5.22 |
| Dec 2025 | 26.1% | (5.26) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| ABBV AbbVie Inc. compare | 32.2% |
| NVS Novartis AG | 25.2% |
| AZN AstraZeneca PLC compare | 23.7% |
| PFE Pfizer Inc. compare | 21.4% |
| JNJ Johnson & Johnson compare | 19.7% |
| MRK Merck & Co., Inc. compare | 9.20% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on NVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement